Julia Ludwig
Julia Ludwig
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,#,
Stephen W Scally
Stephen W Scally
2Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON Canada
3Department of Immunology, University of Toronto, Toronto, ON Canada
2,3,#,
Giulia Costa
Giulia Costa
4Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany
4,#,
Sandro Hoffmann
Sandro Hoffmann
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,
Rajagopal Murugan
Rajagopal Murugan
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,
Jana Lossin
Jana Lossin
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,
Katherine Prieto
Katherine Prieto
2Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON Canada
3Department of Immunology, University of Toronto, Toronto, ON Canada
2,3,
Anna Obraztsova
Anna Obraztsova
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,
Nina Lobeto
Nina Lobeto
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,
Blandine Franke-Fayard
Blandine Franke-Fayard
5Malaria Research Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
5,
Chris J Janse
Chris J Janse
5Malaria Research Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
5,
Celia Lebas
Celia Lebas
6Vaccine Formulation Institute, Plan-les-Ouates, Switzerland
6,
Nicolas Collin
Nicolas Collin
6Vaccine Formulation Institute, Plan-les-Ouates, Switzerland
6,
Spela Binter
Spela Binter
7Kymab a Sanofi Company, Babraham Research Campus, Cambridge, UK
7,
Paul Kellam
Paul Kellam
7Kymab a Sanofi Company, Babraham Research Campus, Cambridge, UK
8Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK
7,8,
Elena A Levashina
Elena A Levashina
4Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany
4,✉,
Hedda Wardemann
Hedda Wardemann
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
1,✉,
Jean-Philippe Julien
Jean-Philippe Julien
2Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON Canada
3Department of Immunology, University of Toronto, Toronto, ON Canada
9Department of Biochemistry, University of Toronto, Toronto, ON Canada
2,3,9,✉
1B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
2Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON Canada
3Department of Immunology, University of Toronto, Toronto, ON Canada
4Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany
5Malaria Research Group, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
6Vaccine Formulation Institute, Plan-les-Ouates, Switzerland
7Kymab a Sanofi Company, Babraham Research Campus, Cambridge, UK
8Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK
9Department of Biochemistry, University of Toronto, Toronto, ON Canada
Subject terms: Malaria, Protein vaccines
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
